PlainRecalls
FDA Devices Moderate Class II Completed

VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagnostic test

Reported: June 11, 2025 Initiated: April 16, 2025 #Z-1903-2025

Product Description

VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagnostic test

Reason for Recall

It was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.

Details

Recalling Firm
Luminex Corporation
Units Affected
89 units
Distribution
US Nationwide distribution in the states of AL, CA, MN, TX, AZ, NJ, WA, SC, VA, GA, VT, CT, MD.
Location
Northbrook, IL

Frequently Asked Questions

What product was recalled?
VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagnostic test. Recalled by Luminex Corporation. Units affected: 89 units.
Why was this product recalled?
It was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 11, 2025. Severity: Moderate. Recall number: Z-1903-2025.